Assessing health-related quality of life in patients with restless legs syndrome

Sleep Medicine

Volumn 10, Issue 3, 2009, Pages 295-305

  Happe, Svenja ^a,b   Reese, Jens Peter ^c   Stiasny Kolster, Karin ^c   Peglau, Ines ^d   Mayer, Geert ^e   Klotsche, Jens ^f   Giani, Guido ^g   Geraedts, Max ^g   Trenkwalder, Claudia ^b,h   Dodel, Richard ^c  

^a KLINIKUM BREMEN OST   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d Private Neurological Practice   (United States)

^e Hephata Klinik   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h PARACELSUS ELENA KLINIK   (Germany)

Author keywords

Depression; EQ 5D; Life satisfaction; Outcome; Quality of life; Restless legs syndrome

Indexed keywords

ANTICONVULSIVE AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; OPIATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMOGRAPHY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; FEMALE; GERMANY; HOUSEHOLD; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SLEEP DISORDER; SOCIAL ASPECT; STROKE; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DEPRESSION; FEMALE; GERMANY; HEALTH STATUS INDICATORS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; SLEEP; YOUNG ADULT;

EID: 64449087455     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2008.01.002     Document Type: Article

References (49)

1. Garcia-Borreguero D., Egatz R., Winkelmann J., and Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 10 (2006) 153-167
2. Milligan S.A., and Chesson A.L. Restless legs syndrome in the older adult: diagnosis and management. Drugs Aging 19 (2002) 741-751
3. Reuther M., Spottke E.A., Klotsche J., et al. Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study. Parkinsonism Relat Disord 13 (2007) 108-114
4. Schrag A., Jahanshahi M., and Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15 (2000) 1112-1118
5. Haacke C., Althaus A., Spottke A., Siebert U., Back T., and Dodel R. Long-term outcome after stroke: evaluating health-related quality of life using utility measurements. Stroke 37 (2006) 193-198
6. Gottberg K., Einarsson U., Ytterberg C., et al. Health-related quality of life in a population-based sample of people with multiple sclerosis in stockholm county. Mult Scler 12 (2006) 605-612
7. Greiner W., Claes C., Busschbach J.J., and Graf von der Schulenburg J.M. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 6 2 (2004) 124-130
8. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., and Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 (2003) 101-119
9. Walters A.S., LeBrocq C., Dhar A., et al. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 4 (2003) 121-132
10. Hays R.D., and Stewart A.L. Sleep measures (1992), Duke University Press, Durham and London
11. Hays R.D., Martin S.A., Sesti A.M., and Spritzer K.L. Psychometric properties of the medical outcomes study sleep measure. Sleep Med 6 (2005) 41-44
12. Richter P., Werner J., Bastine R., Heerlein A., Kick H., and Sauer H. Measuring treatment outcome by the beck depression inventory. Psychopathology 30 (1997) 234-240
13. Greiner W. Die Berechnung von Kosten und Nutzen im Gesundheitswesen. In: Schöffski O., and Schulenburg J.M. (Eds). Gesundheitsökonomische Evaluationen (2000), Springer, Hamburg
14. Statistisches Bundesamt. Statistisches Jahrbuch für die Bundesrepublik Deutschland 2006. Berlin: Statistisches Bundesamt, 2006.
15. Oertel W.H., Trenkwalder C., Zucconi M., et al. State of the art in restless legs syndrome therapy. Practice recommendations for treating restless legs syndrome. Mov Disord 22 (2007) 207-212
16. Reese J.P., Stiasny-Kolster K., Oertel W.H., and Dodel R.C. Health-related quality of life and economic burden in patients with restless legs syndrome. Expert Rev Pharmacoeconomics Outcomes Res 5 (2007) 503-521
17. König H.H., Bernert S., and Angermeyer M.C. Health status of the German population: results of a representative survey using the EuroQol questionnaire. Gesundheitswesen 67 (2005) 173-182
18. Gerhard R., Bosse A., Uzun D., Orth M., and Kotterba S. Quality of life in restless legs syndrome. Influence of daytime sleepiness and fatigue. Med Klin (Munich) 100 (2005) 704-709
19. Kushida C., Martin M., Nikam P., et al. Burden of restless legs syndrome on health-related quality of life. Qual Life Res 16 4 (2007) 617-624
20. Abetz L., Allen R., Follet A., et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther 26 (2004) 925-935
21. Dodel R., Peter H., Spottke A., et al. Health-related quality of life in patients with narcolepsy. Sleep Med 8 7-8 (2007) 733-741
22. McCrink L., Allen R.P., Wolowacz S., Sherrill B., Connolly M., and Kirsch J. Predictors of health-related quality of life in sufferers with restless legs syndrome: a multi-national study. Sleep Med 8 (2007) 73-83
23. Picchietti D., and Winkelman J.W. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 28 (2005) 891-898
24. Rothdach A.J., Trenkwalder C., Haberstock J., Keil U., and Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 54 (2000) 1064-1068
25. Sukegawa T., Itoga M., Seno H., et al. Sleep disturbances and depression in the elderly in Japan. Psychiatry Clin Neurosci 57 (2003) 265-270
26. Addington A.M., Gallo J.J., Ford D.E., and Eaton W.W. Epidemiology of unexplained fatigue and major depression in the community: the Baltimore ECA follow-up, 1981-1994. Psychol Med 31 (2001) 1037-1044
27. Breslau N., Roth T., Rosenthal L., and Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 39 (1996) 411-418
28. Chang P.P., Ford D.E., Mead L.A., Cooper-Patrick L., and Klag M.J. Insomnia in young men and subsequent depression. The Johns Hopkins precursors study. Am J Epidemiol 146 (1997) 105-114
29. Ford D.E., and Kamerow D.B. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. Jama 262 (1989) 1479-1484
30. Ulfberg J., Nystrom B., Carter N., and Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 16 (2001) 1159-1163
31. Banno K., Delaive K., Walld R., and Kryger M.H. Restless legs syndrome in 218 patients: associated disorders. Sleep Med 1 (2000) 221-229
32. Oertel WH, Benes H, Garcia-Borreguero D, et al. Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med 2007;in press.
33. Kohnen R., Benes H., and Kurella B. Development of the disease-specific restless legs syndrome quality of life (RLS-QoL) questionnaire. Mov Disord 17 (2002) P743
34. Kohnen R., Allen R.P., Benes H., et al. Assessment of restless legs syndrome - Methodological approaches for use in practice and clinical trials. Mov Disord 22 Suppl. 18 (2007) S485-S94
35. Trenkwalder C., Benes H., Grote L., et al. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial. Mov Disord 22 (2007) 696-703
36. Oertel W.H., Benes H., Bodenschatz R., et al. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR). Neurology 67 (2006) 1040-1046
37. Atkinson M.J., Allen R.P., DuChane J., Murray C., Kushida C., and Roth T. Validation of the restless legs syndrome quality of life instrument (RLS-QLI): findings of a consortium of national experts and the RLS foundation. Qual Life Res 13 (2004) 679-693
38. Abetz L., Vallow S.M., Kirsch J., Allen R.P., Washburn T., and Earley C.J. Validation of the restless legs syndrome quality of life questionnaire. Value Health 8 (2005) 157-167
39. Trenkwalder C., Stiasny-Kolster K., Kupsch A., Oertel W.H., Koester J., and Reess J. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome. Mov Disord 21 (2006) 1404-1410
40. Winkelman J.W., Sethi K.D., Kushida C.A., et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology 67 (2006) 1034-1039
41. Montplaisir J., Karrasch J., Haan J., and Volc D. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Mov Disord 21 (2006) 1627-1635
42. Walters A.S., Ondo W.G., Dreykluft T., Grunstein R., Lee D., and Sethi K. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord 19 (2004) 1414-1423
43. Trenkwalder C., Garcia-Borreguero D., Montagna P., et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 75 (2004) 92-97
44. Kushida C., Martin M., Nikam P., et al. Burden of restless legs syndrome on health-related quality of life. Qual Life Res 16 (2007) 617-624
45. Gerhard R., Bosse A., Uzun D., Orth M., and Kotterba S. Quality of life in restless legs syndrome. Influence of daytime sleepiness and fatigue. Med Klin (Munich) 100 (2005) 704-709
46. Allen R.P., Walters A.S., Montplaisir J., et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 165 (2005) 1286-1292
47. Berger K., Luedemann J., Trenkwalder C., John U., and Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 164 (2004) 196-202
48. Hening W., Walters A.S., Allen R.P., Montplaisir J., Myers A., and Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 5 (2004) 237-246
49. Winkelman J.W., Eckardt K.M., Müller-Myshok B., and Gasser T. The Restless Legs Syndrome - A Genetic View of the Disease. Das Restless Legs Syndrom aus genetischer Sicht. Somnologie 6 1 (2002) 3-6